Nanobiotechnology and Nanomedicine Companies
(Links listed alphabetically)
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All
Showing results 1 - 18 of 18 for companies starting with B:
BBI Solutions has served the global diagnostics industry for over 50 years, as a leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing – Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.
As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development BioDot is the leading supplier of system tools for the research, development and commercialization of diagnostic tests. As a manufacturer of nanoliter dispensing equipment, BioDot has had extensive experience with the development of manufacturing processes for the protein array industry.
Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.
The company develops clinical diagnostics systems including molecular biology-based assays.
The company is a service partner for all aspects of oligonucleotides. It developed and produced the world's first and only translucent orthodontic systems using novel nanotechnology polymer composite products.
Dental implant technology with nanoscale coatings.
Combining the latest in nanotechnology and biotechnology, the company's Irys System with its nanovhannels allows to visualize the whole genome, capturing extremely long molecules at high resolution.
A bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level.
The company's technology is based on the large scale production of nanometric particles known as VLPs (virus like particles). The most advanced application of this technology is the production of viral vector derived vaccines for human and animal health.
Biontex specializes in the field of transfection technology, the delivery of genes or DNA to eukaryotic cells.
BioPAL provides products and methods to measure in vivo organ function and to track compounds-of-interest in in vivo systems. Products developed for neutron activation technology include nanocolloids for labeling, tracking and quantifying cells in in vivo models.
Develops nanotechnology drug delivery systems based on novel nanomaterials that provide precise control over location and timing of drug delivery.
The company develops its proprietary E-SPR (Enhanced Surface Plasmon Resonance) technology platform for the detection of molecular interactions.
The company has a polymer micro-system technology platform comprising core intellectual property in the areas of polymer multilevel micro- and nano-replication, plastic micro-fluidic chip fabrication and photonics integration, to provide unique products for point-of-use analytical applications.
A life sciences R&D company with a special focus on skin cell biology. The company has established proprietary technologies for nano-liposomal formulation techniques.
The company develops revolutionary microliter and nanoliter scale technology platforms for life sciences and drug discovery research.
Blend Therapeutics is a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases. The company is pioneering an integrative way to discover molecular entities with new mechanisms of action purposely designed for our proprietary nanoparticles. By synergistically developing both the molecule and the nanoparticle together they can make medicines more targeted, more effective and more tolerable.